Metraipolis › archive › dc_2b0d2a16cccb
Receptor tyrosine kinase targeted therapies in glioblastoma: a systematic review — Europe PMC PMID:42824982
- Source
- Europe PMC (en)
- Original
- https://europepmc.org/article/MED/42824982
- DOI
- 10.3389/fmed.2026.1928491
- License (as archived)
- solo-consultazione
- Archived
- 2026-10-09T06:17:46.944Z
- SHA-256 of the archived text
0ae6a8b27f5ed719f8eacfb5afc1902a6d12dfe4b5b0970899daca7eea5d7750- Stable URL of this page
https://metraipolis.com/documento/dc_2b0d2a16cccb
How to cite
Receptor tyrosine kinase targeted therapies in glioblastoma: a systematic review — Europe PMC PMID:42824982 — Europe PMC (en), https://europepmc.org/article/MED/42824982 (solo-consultazione); archived copy: https://metraipolis.com/documento/dc_2b0d2a16cccb (Metraipolis archive dc_2b0d2a16cccb, sha256 0ae6a8b27f5ed719f8eacfb5afc1902a6d12dfe4b5b0970899daca7eea5d7750)
BibTeX
@misc{dc2b0d2a16cccb,
title = {Receptor tyrosine kinase targeted therapies in glioblastoma: a systematic review — Europe PMC PMID:42824982},
howpublished = {Europe PMC (en)},
url = {https://europepmc.org/article/MED/42824982},
note = {License solo-consultazione; archived copy https://metraipolis.com/documento/dc_2b0d2a16cccb; sha256 0ae6a8b27f5ed719f8eacfb5afc1902a6d12dfe4b5b0970899daca7eea5d7750},
year = {2026}
}Archived text
The text is not reproduced here: the archive holds it as solo-consultazione (consultation only, no republication). Read it at the original source: https://europepmc.org/article/MED/42824982. Agents can read the archived copy with the MCP tool read_document.